Preemptive therapy for cytomegalovirus [2]

Liver Transplantation

Volumn 12, Issue 2, 2006, Pages 327-

  Singh, Nina ^a   Yu, Victor L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS ANTIGEN;

COST EFFECTIVENESS ANALYSIS; CYTOMEGALOVIRUS INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; ITALY; LETTER; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; RECIPIENT; SYMPTOM; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOCOMPROMISED HOST; LIVER TRANSPLANTATION; MALE; OPPORTUNISTIC INFECTIONS; PREOPERATIVE CARE; PRIMARY PREVENTION; RISK ASSESSMENT; TRANSPLANTATION IMMUNOLOGY; TREATMENT OUTCOME;

EID: 33244489841     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20676     Document Type: Letter

References (6)

1. Seehofer D, Meisel H, Rayes N, Stein A, Langrehr JM, Settmacher U, Neuhaus P. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation. Am J Transpl 2004;4:1331-1337.
2. Rayes N, Seehofer D, Schmidt CA, Oettle H, Muller AR, Steinmüller T, et al. Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following transplantation. Transplantation 2001;72:881-885.
3. Vivarelli M, De Ruvo N, Lazzarotto T, Bellusci R, Landini MP, Varani S, Cavallari A. Abstension from treatment of low-level pp65 cytomegalovirus antigenemia after liver transplantation: a prospective study. Transplantation 2000; 70:1183-1187.
4. Evans PC, Soin A, Wreghitt TG, Taylor CJ, Wright DGD, Alexander GJM. An association between cytomegalovirus infection and chronic rejection after liver transplantation. Transplantation 2000;69:30-35.
5. Limaye AP, Bakthavatsalam R, Kim HW, Kuhr CS, Halldorson JB, Healey PJ, Boeckh M. Late-onset CMV disease in liver transplant recipients despite antiviral prophylaxis. Transplantation 2004;78:9-16.
6. Singh N, Yu VL. Severing the Gordian Knot of prevention of cytomegalovirus in liver transplatn recipients: the principle is the sword. Liver Transpl 2005;11:891-894.